Federated Hermes, Inc. Night Hawk Biosciences, Inc. Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.65 - $3.13 $943 - $1,790	-572 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.1 - $3.54 $1,218 - $2,053	-580 Reduced 50.35%	572 $2,000
Q4 2021 Feb 14, 2022	BUY	$3.04 - $6.01 $3,502 - $6,923	1,152 New	1,152 $4,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.